KDOQI (Kidney Disease Outcomes Quality Initiative)

NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism
History of KDOQI



KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease


FIGURES

Figure 1.   Pathogenesis of Abnormalities in Mineral Metabolism and Bone Disease in CKD

Figure 2.   Changes in Total Serum Calcium and Inorganic Phosphorus Observed in 11 Uremic Patients Before and After Subtotal Parathyroidectomy

Figure 3.   Example of Summary ROC Analysis

Figure 4.   Relationship Between PTH and Creatinine Clearance Rate

Figure 5.   Summary ROC Analysis of Erosions on X-Ray as Diagnostic for Osteitis Fibrosa

Figure 6.   Plot of GFR vs. BMD T-Score

Figure 7.   Summary ROC Analysis of Intact PTH for Diagnosis of High-Turnover Bone Disease

Figure 8.   Summary ROC Analysis of Intact PTH for Diagnosis of Low-Turnover Bone Disease

Figure 9.   Relationship Between Serum Phosphorus and Creatinine Clearance Rate (CCR)

Figure 10. Meta-Analysis of Size of Effect on Serum Phosphorus Levels of Calcium Acetate vs. Calcium Carbonate

Figure 11. Meta-Analysis of Size of Hypercalcemic Effect of Calcium Carbonate vs. Other Phosphate Binders

Figure 12. Meta-Analysis of Oral Versus Intravenous Calcitriol on PTH Suppression

Figure 13. Summary Odds Ratio of Being Diagnosed with A 2M Over Time on Dialysis

Figure 14. Individual Study and Summary Effect Sizes for the Effect of DFO Therapy on Bone Formation Rate

Figure 15. Individual Study and Summary Effect Sizes for the Effect of DFO Therapy on Bone Surface Aluminum Stain

Figure 16. Effect Sizes and 95% Confidence Interval of RCTs and Retrospective Studies Reporting Incidence of Necrosis

 


2003 National Kidney Foundation, Inc.